7,376.86

+23.13

+0.31%

51,285.73

-237.33

-0.46%

24,579.42

+264.43

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,720.23

+35.83

+0.05%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

HKSE - Delayed Quote HKD

Man Yue Technology Holdings Limited (0894.HK)

1.185 -0.035 (-2.87%)

At close: November 6 at 4:08:50 PM GMT+8

Volume, Not Price, Drove the Surprise at Procter & Gamble (PG)

Insider Monkey 36m ago

PG

^DJI

^GSPC
Why Nvidia Stock Looks Like a Bargain Right Now

Motley Fool 59m ago

NVDA
SoFi Has 17.1 Million Members. Prediction: It Tops 20 Million in 2027.

Motley Fool 1h ago

SOFI

NVDA
The 1 Stock I'd Buy With $2,500 in November and Not Check Until 2051

Motley Fool 19m ago

NVDA
Revolution Medicines' Pancreatic Cancer Drug Nearly Doubled Survival. Is the High-Flying Stock Still a Buy?

Motley Fool 1h ago

RVMD

NVDA
Wall Street Is Dumping AI Stocks Even as Business Booms. Something Doesn’t Add Up.

24/7 Wall St. 1h ago

AMD

PLTR
Green Thumb Ended Its String of Profitable Quarters. Is the Stock a Buy?

Motley Fool 34m ago

GTII.CN

NVDA
A Record 1.28 Billion Barrels of Oil Are Stuck at Sea — and That Could Mean Higher Gas Prices

24/7 Wall St. 1h ago

CL=F
Why Nvidia at 13 Times Expected Earnings Still Isn’t Cheap

24/7 Wall St. 2h ago

NVDA
This Dividend King Has Raised Its Payout Through Every Recession Since the 1950s. I'm Buying Before the End of the Year.

Motley Fool 2h ago

PG

NVDA
Why Royalty Pharma Investors Could Be the Quiet Winners From Revolution Medicines' Groundbreaking Pancreatic Cancer Drug

Motley Fool 2h ago

RVMD

RPRX
No Matter What Happens to the S&P 500 in November, These 3 Dividend Stocks Belong in Your Portfolio

Motley Fool 1h ago

^GSPC

NVDA

Performance Overview

Return	0894.HK	HANG SENG INDEX (^HSI)
YTD	+55.92%	-4.48%
1-Year	+42.77%	-7.57%
3-Year	+178.91%	+36.26%

Mobilize your Website

View Site in Mobile | Classic

Share by: